Press releases

Boston Scientific Corporation (NYSE: BSX) today announced results from a pooled analysis of patients from its TAXUS IV and TAXUS...

Boston Scientific Corporation (NYSE: BSX) today welcomed favorable outcomes of one- year data from the Company's TAXUS IV and V...

Boston Scientific Corporation (NYSE: BSX) today welcomed positive two-year results from Abbott's prospective, randomized (3:1), single...

Boston Scientific Corporation (NYSE: BSX) today announced the sale of Boston Scientific Santa Rosa Corp., formerly known as TriVascular, Inc., to...

Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of two-year data from more than 7,000 patients in...

Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of 4,772 patients from its TAXUS ARRIVE 1 and 2...

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the Society for...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lehman Brothers Health Care Conference, which is being held March 18...

Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its ACUITY® Spiral left ventricular lead for use with cardiac...

Boston Scientific Corporation (NYSE: BSX) today announced the first European implants of its COGNIS™ cardiac resynchronization therapy...

Boston Scientific Corporation (NYSE: BSX) today announced that Jay J. Schnitzer, M.D., Ph.D. will be joining the Company's Clinical Sciences...

Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval for three products in its Cardiac Rhythm...

Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Fluid Management and Venous Access businesses to...

Boston Scientific Corporation (NYSE: BSX) today announced that a U.S. District Court jury in Marshall, Texas has reached a verdict in a patent...

Boston Scientific Corporation (NYSE: BSX) today announced that the first patient has been enrolled in its PROENCY (PROMUS™, ENdeavor® and...

Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and full year ended December 31, 2007, as well as...

Boston Scientific Corporation (NYSE: BSX) today announced the public debut of an educational initiative called "Close the Gap," which is aimed at...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical...

Boston Scientific (NYSE: BSX) today issued the following statement from Donald S. Baim, M.D., Chief Medical and Scientific Officer, on an article in the New...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended...

Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval for its COGNIS™ cardiac resynchronization therapy defibrillator...

Boston Scientific Corporation (NYSE: BSX) today announced that the Court of Appeals for the Federal Circuit affirmed a District Court ruling which...

Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Cardiac Surgery and Vascular Surgery businesses to...

Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of the controlling interests in its auditory business and...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming JP Morgan Health Care Conference, in San Francisco. Paul...